Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/17154
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan den Bosch, Caroline M. A.-
dc.contributor.authorHulscher, Marlies E. J. L.-
dc.contributor.authorNatsch, Stephanie-
dc.contributor.authorGYSSENS, Inge-
dc.contributor.authorPrins, Jan M.-
dc.contributor.authorGeerlings, Suzanne E.-
dc.date.accessioned2014-09-18T15:50:07Z-
dc.date.available2014-09-18T15:50:07Z-
dc.date.issued2014-
dc.identifier.citationBMC INFECTIOUS DISEASES, 14-
dc.identifier.issn1471-2334-
dc.identifier.urihttp://hdl.handle.net/1942/17154-
dc.description.abstractBackground: Outcomes in patients with sepsis are better if initial empirical antimicrobial use is appropriate. Several studies have shown that adherence to guidelines dictating appropriate antimicrobial use positively influences clinical outcome, shortens length of hospital stay and contributes to the containment of antibiotic resistance. Quality indicators (QIs) can be systematically developed from these guidelines to define and measure appropriate antimicrobial use. We describe the development of a concise set of QIs to assess the appropriateness of antimicrobial use in adult patients with sepsis on a general medical ward or Intensive Care Unit (ICU). Methods: A RAND-modified, five step Delphi procedure was used. A multidisciplinary panel of 14 experts appraised and prioritized 40 key recommendations from within the Dutch national guideline on antimicrobial use for adult hospitalized patients with sepsis (www.swab.nl/guidelines). A procedure to select QIs relevant to clinical outcome, antimicrobial resistance and costs was performed using two rounds of questionnaires with a face-to-face consensus meeting between the rounds over a period of three months. Results: The procedure resulted in the selection of a final set of five QIs, namely: obtain cultures; prescribe empirical antimicrobial therapy according to the national guideline; start intravenous drug therapy; start antimicrobial treatment within one hour; and streamline antimicrobial therapy. Conclusion: This systematic, stepwise method, which combined evidence and expert opinion, led to a concise and therefore feasible set of QIs for optimal antimicrobial use in hospitalized adult patients with sepsis. The next step will entail subjecting these quality indicators to an applicability test for their clinimetric properties and ultimately, using these QIs in quality-improvement projects. This information is crucial for antimicrobial stewardship teams to help set priorities and to focus improvement.-
dc.description.sponsorshipThis work was supported by Zon/MW, the Netherlands Organisation for Health Research and Development, project number 205100003.-
dc.language.isoen-
dc.publisherBIOMED CENTRAL LTD-
dc.rights© 2014 van den Bosch et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.-
dc.subject.otherSepsis; Antimicrobial treatment; Quality indicator; Quality improvement; Appropriate antimicrobial use; Appropriate antibiotic use-
dc.subject.othersepsis; antimicrobial treatment; quality indicator; quality improvement; appropriate antimicrobial use; appropriate antibiotic use-
dc.titleDevelopment of quality indicators for antimicrobial treatment in adults with sepsis-
dc.typeJournal Contribution-
dc.identifier.volume14-
local.format.pages10-
local.format.pages10-
local.bibliographicCitation.jcatA1-
dc.description.notes[van den Bosch, Caroline M. A.; Prins, Jan M.; Geerlings, Suzanne E.] Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands. [Hulscher, Marlies E. J. L.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, NL-6525 ED Nijmegen, Netherlands. [Natsch, Stephanie] Radboud Univ Nijmegen, Med Ctr, Dept Clin Pharm, NL-6525 ED Nijmegen, Netherlands. [Gyssens, Inge C.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands. [Gyssens, Inge C.] Canisius Wilhelmina Ziekenhuis, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands. [Gyssens, Inge C.] Hasselt Univ, Hasselt, Belgium.-
local.publisher.placeLONDON-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1186/1471-2334-14-345-
dc.identifier.isi000338168000001-
item.accessRightsOpen Access-
item.contributorvan den Bosch, Caroline M. A.-
item.contributorHulscher, Marlies E. J. L.-
item.contributorNatsch, Stephanie-
item.contributorGYSSENS, Inge-
item.contributorPrins, Jan M.-
item.contributorGeerlings, Suzanne E.-
item.fulltextWith Fulltext-
item.fullcitationvan den Bosch, Caroline M. A.; Hulscher, Marlies E. J. L.; Natsch, Stephanie; GYSSENS, Inge; Prins, Jan M. & Geerlings, Suzanne E. (2014) Development of quality indicators for antimicrobial treatment in adults with sepsis. In: BMC INFECTIOUS DISEASES, 14.-
item.validationecoom 2015-
crisitem.journal.eissn1471-2334-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1471-2334-14-345.pdf240.19 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

18
checked on Sep 7, 2020

WEB OF SCIENCETM
Citations

27
checked on Apr 14, 2024

Page view(s)

58
checked on Sep 5, 2022

Download(s)

110
checked on Sep 5, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.